The involvement of the NF-κB pathway in ischemic stroke makes it an attractive target for the development of anti-inflammatory drugs to treat ischemia-reperfusion injury (Howell and Bidwell, 2020). This evidence concerns the gene NFKB1 and ischemic stroke.